Edgewise Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/12/2026 | 6.63 M | $164.54 M | 4.39% | 6.29% |
| VANGUARD GROUP INC | 01/29/2026 | 4.87 M | $120.89 B | 1.41% | 4.62% |
| SIREN, L.L.C. | 02/13/2026 | 4.53 M | $112.41 M | 16.24% | 4.29% |
| MORGAN STANLEY | 02/13/2026 | 2.91 M | $72.23 M | 234.71% | 2.76% |
| UBS GROUP AG | 01/29/2026 | 2.12 M | $52.54 M | 1,755.00% | 2.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 1.75 M | $43.34 B | 1.66% | 1.66% |
| STATE STREET CORP | 02/13/2026 | 1.72 M | $42.62 M | 1.03% | 1.63% |
| BIOIMPACT CAPITAL LLC | 02/17/2026 | 1.66 M | $41.08 M | -3.81% | 1.57% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 1.47 M | $36.60 B | 359.25% | 1.40% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 1.21 M | $30.11 M | 2.58% | 1.15% |
| AMERICAN CENTURY COMPANIES INC | 02/13/2026 | 1.19 M | $29.44 M | 8.31% | 1.12% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 02/12/2026 | 910.00 K | $22.58 M | 100.00% | 0.86% |
| ABRDN PLC | 01/16/2026 | 821.94 K | $20.40 M | 32.60% | 0.78% |
| NORGES BANK | 02/10/2026 | 751.36 K | $18.64 M | 100.00% | 0.71% |
| VICTORY CAPITAL MANAGEMENT INC | 02/13/2026 | 746.56 K | $18.53 M | 49.72% | 0.71% |
| GOLDMAN SACHS GROUP INC | 02/10/2026 | 718.37 K | $17.83 B | 36.10% | 0.68% |
| MARSHALL WACE, LLP | 02/13/2026 | 681.92 K | $16.93 M | 100.00% | 0.65% |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 02/13/2026 | 640.40 K | $15.89 M | 100.00% | 0.61% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 611.38 K | $15.17 M | 2.31% | 0.58% |
| EVENTIDE ASSET MANAGEMENT, LLC | 02/13/2026 | 568.31 K | $14.10 M | 0.00% | 0.54% |
| CANDRIAM S.C.A. | 02/13/2026 | 501.21 K | $12.44 M | 126.63% | 0.48% |
| SOFINNOVA INVESTMENTS, INC. | 02/13/2026 | 437.82 K | $10.86 M | -15.84% | 0.42% |
| PARKMAN HEALTHCARE PARTNERS LLC | 02/17/2026 | 427.69 K | $10.61 M | -22.26% | 0.41% |
| BARCLAYS PLC | 02/13/2026 | 372.74 K | $9.25 M | 58.85% | 0.35% |
| UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH | 01/28/2026 | 271.39 K | $6.73 M | 104.81% | 0.26% |
| KENNEDY CAPITAL MANAGEMENT LLC | 02/13/2026 | 241.51 K | $5.99 M | -3.64% | 0.23% |
| CITIGROUP INC | 02/13/2026 | 223.29 K | $5.54 M | -58.53% | 0.21% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 214.77 K | $5.33 M | 38.65% | 0.20% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 198.61 K | $4.93 M | -2.76% | 0.19% |
| NUVEEN, LLC | 02/12/2026 | 169.47 K | $4.21 M | -1.88% | 0.16% |
| DAFNA CAPITAL MANAGEMENT LLC | 02/17/2026 | 159.74 K | $3.96 M | -25.26% | 0.15% |
| JPMORGAN CHASE & CO | 02/11/2026 | 146.04 K | $3.62 M | 112.51% | 0.14% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 02/13/2026 | 145.29 K | $3.57 M | -3.82% | 0.14% |
| NEUBERGER BERMAN GROUP LLC | 02/13/2026 | 127.14 K | $3.15 M | -42.12% | 0.12% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 126.44 K | $3.14 M | -82.57% | 0.12% |
| CITADEL ADVISORS LLC | 02/17/2026 | 123.10 K | $3.05 B | 451.58% | 0.12% |
| QUANTUM PRIVATE WEALTH, LLC | 02/06/2026 | 106.02 K | $2.63 M | 0.14% | 0.10% |
| SWISS NATIONAL BANK | 02/12/2026 | 103.90 K | $2.58 M | 1.96% | 0.10% |
| EXOME ASSET MANAGEMENT LLC | 02/13/2026 | 100.05 K | $2.48 M | -42.32% | 0.09% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/13/2026 | 98.06 K | $2.43 M | -29.51% | 0.09% |
| NEW YORK STATE COMMON RETIREMENT FUND | 02/12/2026 | 88.94 K | $2.21 M | 6.59% | 0.08% |
| SG AMERICAS SECURITIES, LLC | 01/09/2026 | 88.72 K | $2.20 M | 797.92% | 0.08% |
| ALPS ADVISORS INC | 02/12/2026 | 86.93 K | $2.16 M | 70.08% | 0.08% |
| RHUMBLINE ADVISERS | 02/13/2026 | 85.08 K | $2.11 B | -18.84% | 0.08% |
| FEDERATED HERMES, INC. | 02/12/2026 | 82.10 K | $2.04 M | 38.54% | 0.08% |
| DEKABANK DEUTSCHE GIROZENTRALE | 01/28/2026 | 80.00 K | $1.56 M | 0.00% | 0.08% |
| JUMP FINANCIAL, LLC | 02/17/2026 | 79.92 K | $1.98 M | -1.13% | 0.08% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 78.20 K | $1.94 M | 2.22% | 0.07% |
| WELLS FARGO & COMPANY/MN | 02/13/2026 | 75.44 K | $1.87 M | 78.79% | 0.07% |
| CITADEL ADVISORS LLC | 02/17/2026 | 73.50 K | $1.82 B | 59.44% | 0.07% |
Edgewise Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 161 institutional investors and hedge funds held shares of Edgewise Therapeutics Inc. The most heavily invested institutionals were:
BlackRock, Inc.: 6.63 M
VANGUARD GROUP INC: 4.87 M
Siren, L.L.C.: 4.53 M
MORGAN STANLEY: 2.91 M
UBS Group AG: 2.12 M
GEODE CAPITAL MANAGEMENT, LLC: 1.75 M
32.91% of Edgewise Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 46.98 M shares in the last 24 months. This purchase volume represents approximately $1.39 B in transactions.